Terminated PHASE4 INTERVENTIONAL 2-arm NCT01593319

Is Regional Anesthesia of the Hip Preferable Over Traditional Analgesia in the Acute Stage of the Management of Patients With a Fracture of the Hip

Sponsor: Landstinget i Värmland

Interventions Natrium chloride Ropivacaine

Updated 5 times since 2017 Last updated: Apr 17, 2015 Started: Jan 31, 2012 Primary completion: Apr 30, 2015 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other Hip Fractures trials with similar outcome

Browse all Hip Fractures trials

A PHASE4 clinical study on Hip Fractures, this trial is terminated or withdrawn. The trial is conducted by Landstinget i Värmland and has accumulated 5 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE4

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Landstinget i Värmland

Data source: Landstinget i Värmland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karlstad, Sweden